[The expression of hepatocyte growth factor and its receptor in brain astrocytomas]. 2005

Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
Department of Neurosurgery, Wuhan University Zhongnan Hospital, Wuhan 430071, China.

OBJECTIVE To investigate the expression of hepatocyte growth factor (HGF) mRNA and its receptor (c-Met) mRNA in brain astrocytomas and their relationships with tumor proliferation, angiogenesis, clinical pathology and prognosis. METHODS The expression of HGF mRNA, c-Met mRNA in the resected tumor tissues of 76 patients with brain astrocytomas, 43 males and 33 females, aged 20 - 71, were detected by in situ hybridization. Immunohistochemistry technique was used to test the expression of proliferating cell nuclear antigen (PCNA) protein and the microvessel density (MVD) was determined by immunohistochemistry with monoclonal antibody against CD34. RESULTS The positive rates of expression of HGF, c-Met and PCNA in low pathologic grades of brain astrocytoma were 34.5%, 44.8% and 15% +/- 9% respectively, and in high pathologic grades of brain astrocytoma were 34.5%, 44.8% and 48% +/- 12% respectively (P < 0.05). MVD in low and high pathologic grades of brain astrocytoma were 17 +/- 7 and 31 +/- 13 respectively (P < 0.05). The expression of HGF, c-Met, PCNA and CD34 was not related to sex, age, position of tumor and diameter of tumor. The expression of c-Met was related to the expression of HGF, PCNA and the MVD in the tumor tissues of these patients. The pathological grade, position of tumor, HGF, c-Met, PCNA, MVD had a significant influence on the survival time. CONCLUSIONS HGF/c-Met plays an important role in the formation and progression of the brain astrocytoma and can promote tumor proliferation and intratumoral microvascular formation, and is closely related to the prognosis of the patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001254 Astrocytoma Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) Astrocytoma, Subependymal Giant Cell,Glioma, Astrocytic,Oligoastrocytoma, Mixed,Pleomorphic Xanthoastrocytomas,Anaplastic Astrocytoma,Astrocytoma, Grade I,Astrocytoma, Grade II,Astrocytoma, Grade III,Astrocytoma, Protoplasmic,Astroglioma,Cerebral Astrocytoma,Childhood Cerebral Astrocytoma,Fibrillary Astrocytoma,Gemistocytic Astrocytoma,Intracranial Astrocytoma,Juvenile Pilocytic Astrocytoma,Pilocytic Astrocytoma,Subependymal Giant Cell Astrocytoma,Anaplastic Astrocytomas,Astrocytic Glioma,Astrocytic Gliomas,Astrocytoma, Anaplastic,Astrocytoma, Cerebral,Astrocytoma, Childhood Cerebral,Astrocytoma, Fibrillary,Astrocytoma, Gemistocytic,Astrocytoma, Intracranial,Astrocytoma, Juvenile Pilocytic,Astrocytoma, Pilocytic,Astrocytomas,Astrocytomas, Grade III,Astrogliomas,Cerebral Astrocytoma, Childhood,Cerebral Astrocytomas,Childhood Cerebral Astrocytomas,Fibrillary Astrocytomas,Gemistocytic Astrocytomas,Gliomas, Astrocytic,Grade I Astrocytoma,Grade I Astrocytomas,Grade II Astrocytoma,Grade II Astrocytomas,Grade III Astrocytoma,Grade III Astrocytomas,Intracranial Astrocytomas,Juvenile Pilocytic Astrocytomas,Mixed Oligoastrocytoma,Mixed Oligoastrocytomas,Pilocytic Astrocytoma, Juvenile,Pilocytic Astrocytomas,Pleomorphic Xanthoastrocytoma,Protoplasmic Astrocytoma,Protoplasmic Astrocytomas,Xanthoastrocytoma, Pleomorphic

Related Publications

Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
April 2001, Neuro-oncology,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
November 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
July 1993, Stem cells (Dayton, Ohio),
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
July 1994, The Journal of cell biology,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
July 1997, Brain research,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
January 2018, Oncology letters,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
June 2000, Biology of reproduction,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
January 1998, The Histochemical journal,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
October 1995, Journal of neuro-oncology,
Sheng-Hua Chu, and Xian-Hou Yuan, and Pu-Cha Jiang, and Zhi-Qiang Li, and Jie Zhang, and Zhi-Hua Wen, and Shi-Yu Zhao, and Xin-Jun Chen, and Chang-Jun Cao
January 2000, Andrologia,
Copied contents to your clipboard!